Firebird Diagnostics LLC

FireLAMP-HPV^TM

Home
Product Pipeline
FireLAMP-HPV^TM

FireLAMP-HPV^TM

A point of care assay for low resource environments to prevent cervical cancer deaths

Exploits FireLAMP technologies
Supported by an India-US binational development grant
Identifies both high risk and low risk viruses

FireLAMP-HPV

Performance

Samples: Cervical swabs, urine
Targets: Serotypes 16 18 31 33 35 39 45 51 52 56 58 59 66 68
Targets L1 region and/or E6/E7 region
Internal control. Human beta globulin
Sensitivity: < 50 copies per sample
Signal generation: < 30 minutes
Instruments: Most RT-PCR instruments

Commercial

Anticipated use in rural India, other low resource environments
Firebird ships components worldwide for local assembly
Enzymes can be sourced locally or from Firebird
Partnership with Genepath in India
Partner in Sichuan Provide, China

Technology & Publications

Powered by ProbeLAMP^TM technology

Yaren et al. (2021) Isothermal Amplification of Oligonucleotides. US Patent 10920267

Related Products

An new test in our family of FireLAMP^TM products. See also:

FireLAMP-COVID^TM
FireLAMP-DiagnosTicks^TM